Arsenic Exposure and Type 2 Diabetes: A Systematic Review of the Experimental and Epidemiologic Evidence
Ana Navas‐Acién(University of Southern California), Eliseo Güallar(Spanish National Centre for Cardiovascular Research), Robin A. Streeter(Johns Hopkins University), Ellen K. Silbergeld, Jeanne M. Clark(Johns Hopkins University), Thomas A. Burke
Cited by 340
Related Papers
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Social Determinants of Health and Diabetes: A Scientific Review
|Diabetes Care|2020|1.6k
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
|Diabetes Care|2007|1.5k
Lead Exposure and Cardiovascular Disease—A Systematic Review
|Environmental Health Perspectives|2006|1.1k